Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The macrophage scavenger receptor A is host-protective in experimental meningococcal septicaemia.

Plüddemann A, Hoe JC, Makepeace K, Moxon ER, Gordon S.

PLoS Pathog. 2009 Feb;5(2):e1000297. doi: 10.1371/journal.ppat.1000297. Epub 2009 Feb 13.

2.

Identification of Neisseria meningitidis nonlipopolysaccharide ligands for class A macrophage scavenger receptor by using a novel assay.

Peiser L, Makepeace K, Plüddemann A, Savino S, Wright JC, Pizza M, Rappuoli R, Moxon ER, Gordon S.

Infect Immun. 2006 Sep;74(9):5191-9.

3.

The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses.

Peiser L, De Winther MP, Makepeace K, Hollinshead M, Coull P, Plested J, Kodama T, Moxon ER, Gordon S.

Infect Immun. 2002 Oct;70(10):5346-54.

4.

The adhesin complex protein (ACP) of Neisseria meningitidis is a new adhesin with vaccine potential.

Hung MC, Heckels JE, Christodoulides M.

MBio. 2013 Feb 26;4(2). pii: e00041-13. doi: 10.1128/mBio.00041-13.

5.

Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival.

Echenique-Rivera H, Muzzi A, Del Tordello E, Seib KL, Francois P, Rappuoli R, Pizza M, Serruto D.

PLoS Pathog. 2011 May;7(5):e1002027. doi: 10.1371/journal.ppat.1002027. Epub 2011 May 5.

6.

SR-A, MARCO and TLRs differentially recognise selected surface proteins from Neisseria meningitidis: an example of fine specificity in microbial ligand recognition by innate immune receptors.

Plüddemann A, Mukhopadhyay S, Sankala M, Savino S, Pizza M, Rappuoli R, Tryggvason K, Gordon S.

J Innate Immun. 2009;1(2):153-63. doi: 10.1159/000155227. Epub 2008 Sep 11.

PMID:
20375573
7.

The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease.

Fransen F, Hamstra HJ, Boog CJ, van Putten JP, van den Dobbelsteen GP, van der Ley P.

Infect Immun. 2010 Jul;78(7):3177-86. doi: 10.1128/IAI.01311-09. Epub 2010 May 3.

8.

Role of transferrin receptor from a Neisseria meningitidis tbpB isotype II strain in human transferrin binding and virulence.

Renauld-Mongénie G, Poncet D, Mignon M, Fraysse S, Chabanel C, Danve B, Krell T, Quentin-Millet MJ.

Infect Immun. 2004 Jun;72(6):3461-70.

9.

Development and evaluation of an improved mouse model of meningococcal colonization.

Yi K, Stephens DS, Stojiljkovic I.

Infect Immun. 2003 Apr;71(4):1849-55.

10.

Important role for Toll-like receptor 9 in host defense against meningococcal sepsis.

Sjölinder H, Mogensen TH, Kilian M, Jonsson AB, Paludan SR.

Infect Immun. 2008 Nov;76(11):5421-8. doi: 10.1128/IAI.00615-08. Epub 2008 Sep 15.

11.

Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cells.

Quattroni P, Li Y, Lucchesi D, Lucas S, Hood DW, Herrmann M, Gabius HJ, Tang CM, Exley RM.

Cell Microbiol. 2012 Nov;14(11):1657-75. doi: 10.1111/j.1462-5822.2012.01838.x. Epub 2012 Aug 12.

12.

Identification by genomic immunization of a pool of DNA vaccine candidates that confer protective immunity in mice against Neisseria meningitidis serogroup B.

Yero D, Pajón R, Pérez Y, Fariñas M, Cobas K, Diaz D, Solis RL, Acosta A, Brookes C, Taylor S, Gorringe A.

Vaccine. 2007 Jul 9;25(28):5175-88. Epub 2007 May 21.

PMID:
17544180
13.

Suppression of TLR4-mediated inflammatory response by macrophage class A scavenger receptor (CD204).

Ohnishi K, Komohara Y, Fujiwara Y, Takemura K, Lei X, Nakagawa T, Sakashita N, Takeya M.

Biochem Biophys Res Commun. 2011 Aug 5;411(3):516-22. doi: 10.1016/j.bbrc.2011.06.161. Epub 2011 Jul 2.

PMID:
21756882
14.
15.

Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidis.

Vu DM, Shaughnessy J, Lewis LA, Ram S, Rice PA, Granoff DM.

Infect Immun. 2012 Feb;80(2):643-50. doi: 10.1128/IAI.05604-11. Epub 2011 Nov 21.

16.

LPS from Neisseria meningitidis is crucial for inducing monocyte- and microparticle-associated tissue factor activity but not for tissue factor expression.

Øvstebø R, Aass HC, Haug KB, Trøseid AM, Gopinathan U, Kierulf P, Berg JP, Brandtzaeg P, Henriksson CE.

Innate Immun. 2012 Aug;18(4):580-91. doi: 10.1177/1753425911428230. Epub 2011 Dec 16.

PMID:
22180561
17.

Lipooligosaccharide structure contributes to multiple steps in the virulence of Neisseria meningitidis.

Plant L, Sundqvist J, Zughaier S, Lövkvist L, Stephens DS, Jonsson AB.

Infect Immun. 2006 Feb;74(2):1360-7.

18.

Assessment of vaccine potential of the Neisseria-specific protein NMB0938.

Sardiñas G, Climent Y, Rodríguez Y, González S, García D, Cobas K, Caballero E, Pérez Y, Brookes C, Taylor S, Gorringe A, Delgado M, Pajón R, Yero D.

Vaccine. 2009 Nov 16;27(49):6910-7. doi: 10.1016/j.vaccine.2009.09.005. Epub 2009 Sep 12.

PMID:
19751688
19.

A regulatory role for macrophage class A scavenger receptors in TLR4-mediated LPS responses.

Chen Y, Wermeling F, Sundqvist J, Jonsson AB, Tryggvason K, Pikkarainen T, Karlsson MC.

Eur J Immunol. 2010 May;40(5):1451-60. doi: 10.1002/eji.200939891.

20.

Carbohydrate composition of meningococcal lipopolysaccharide modulates the interaction of Neisseria meningitidis with human dendritic cells.

Kurzai O, Schmitt C, Claus H, Vogel U, Frosch M, Kolb-Mäurer A.

Cell Microbiol. 2005 Sep;7(9):1319-34.

PMID:
16098219
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk